Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H8Cl2N2 |
| Molecular Weight | 275.133 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC(\C=C(/C#N)C2=CC=CN=C2)=CC(Cl)=C1
InChI
InChIKey=TYXIVBJQPBWBHO-UUILKARUSA-N
InChI=1S/C14H8Cl2N2/c15-13-5-10(6-14(16)7-13)4-12(8-17)11-2-1-3-18-9-11/h1-7,9H/b12-4+
| Molecular Formula | C14H8Cl2N2 |
| Molecular Weight | 275.133 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| EGFR- and AKT-mediated reduction in PTEN expression contributes to tyrphostin resistance and is reversed by mTOR inhibition in endometrial cancer cells. | 2012-02 |
|
| The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice. | 1991-08-15 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:12:28 GMT 2025
by
admin
on
Mon Mar 31 18:12:28 GMT 2025
|
| Record UNII |
Y42W2Q9ZPP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
138989-57-8
Created by
admin on Mon Mar 31 18:12:28 GMT 2025 , Edited by admin on Mon Mar 31 18:12:28 GMT 2025
|
PRIMARY | |||
|
C1667
Created by
admin on Mon Mar 31 18:12:28 GMT 2025 , Edited by admin on Mon Mar 31 18:12:28 GMT 2025
|
PRIMARY | |||
|
Y42W2Q9ZPP
Created by
admin on Mon Mar 31 18:12:28 GMT 2025 , Edited by admin on Mon Mar 31 18:12:28 GMT 2025
|
PRIMARY | |||
|
5926218
Created by
admin on Mon Mar 31 18:12:28 GMT 2025 , Edited by admin on Mon Mar 31 18:12:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |